SCHEMBL30784382

SCHEMBL30784382

CCNC(=O)c1cc(C)cc(Br)c1N

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.39
ALDH1A1 P00352 3/20 0.38
PLAU P00749 2/20 0.37
F2 P00734 1/20 0.37
F10 P00742 1/20 0.37
PLG P00747 1/20 0.37
PLAT P00750 1/20 0.37
LMNA P02545 1/20 0.37
CA2 P00918 5/20 0.37
CA4 P22748 4/20 0.37
CA12 O43570 1/20 0.37
CA1 P00915 1/20 0.37
CA3 P07451 1/20 0.37
CA6 P23280 1/20 0.37
CA5A P35218 1/20 0.37
CA7 P43166 1/20 0.37
CA9 Q16790 1/20 0.37
CA13 Q8N1Q1 1/20 0.37
CA14 Q9ULX7 1/20 0.37
CA5B Q9Y2D0 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13753822 1.00 KDM4E (0.39) KDM4EALDH1A1PLAUF2F10
SCHEMBL27993371 0.85 KDM4E (0.43) KDM4EALDH1A1PLAUF2F10
SCHEMBL13753819 0.83 KDM4E (0.58) KDM4EALDH1A1LMNASMN1; SMN2MAPT
SCHEMBL25170294 0.81 KDM4E (0.42) KDM4EALDH1A1PLAUF2F10
SCHEMBL30784363 0.79 POLB (0.50) KDM4EALDH1A1CA2ACHESMN1; SMN2
SCHEMBL31392512 0.78 KDM4E (0.42) KDM4EALDH1A1PLAUF2F10
SCHEMBL29101565 0.77 KDM4E (0.39) KDM4EALDH1A1LMNACYP1A2SMN1; SMN2
SCHEMBL38657665 0.77 KDM4E (0.39) KDM4EALDH1A1PLAUF2F10
SCHEMBL30784123 0.77 ALOX5 (0.46) KDM4EALDH1A1PLAUF2F10
SCHEMBL21381603 0.77 F2R (0.53) LMNASMN1; SMN2MAPTRAB9AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024026424-A1 QUINAZOLINONE DERIVATIVES AS AND RELATED USES BLACK DIAMOND THERAPEUTICS, INC. (US) 2024-02-01 WO disclosed